These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1071963)

  • 1. Discussion paper: tumor-directed cellular hypersensitivity detected by leucocyte migration in patients with renal carcinoma.
    Kjaer M; Bendixen G
    Ann N Y Acad Sci; 1976; 276():260-71. PubMed ID: 1071963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison between the direct capillary tube leucocyte migration technique (LMCT) and the direct agarose leucocyte migration technique (LMAT) as indicators of tumour-directed cell-mediated hypersensitivity (TCMH) in patients with renal carcinoma.
    Kjaer M; Sorensen IB
    Acta Allergol; 1976 Apr; 31(2):141-58. PubMed ID: 947138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agarose microdroplet leucocyte migration technique for detection of cell-mediated hypersensitivity to PPD and renal carcinoma antigen.
    Sorensen TB; Kjaer M
    Clin Exp Immunol; 1977 Oct; 30(1):168-72. PubMed ID: 606436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro demonstration of cellular hypersensitivity to tumour antigens by means of the leucocyte migration technique in patients with renal carcinoma.
    Kjaer M
    Eur J Cancer (1965); 1974 Aug; 10(8):523-31. PubMed ID: 4463002
    [No Abstract]   [Full Text] [Related]  

  • 5. General immunocompetence and tumour-directed, cell-mediated hypersensitivity in vitro in patients with renal carcinoma.
    Kjaer M; Thomsen M
    Acta Pathol Microbiol Scand C; 1976 Oct; 84C(5):403-13. PubMed ID: 136864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of tumour-directed, cell-mediated hypersensitivity detected by means of the leucocyte migration technique in patients with renal carcinoma.
    Kjaer M
    Eur J Cancer (1965); 1976 Nov; 12(11):889-98. PubMed ID: 991899
    [No Abstract]   [Full Text] [Related]  

  • 7. Cell-mediated immunity in patients with renal cell carcinoma as measured by leukocyte migration inhibition test.
    Wright GL; Schellhammer PF; Rosato FE; Faulconer RJ
    Urology; 1978 Nov; 12(5):525-31. PubMed ID: 726170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The capillary tube leucocyte migration technique (LMT) as a method for detection of serum inhibiting activity of tumour-directed, cellular hypersensitivity in patients with renal carcinomas.
    Kjoer M
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1974 Apr; 82(2):294-6. PubMed ID: 4528017
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of leucocyte washings on cellular immunity to human renal carcinoma.
    Kjaer M
    Eur J Cancer (1965); 1976 Oct; 12(10):783-92. PubMed ID: 1086209
    [No Abstract]   [Full Text] [Related]  

  • 10. [Tumor specific, cellular immune response in vitro, in patients with hypernephroma].
    Pappas A; Schwarze G; König K; Scheurlen PG
    Verh Dtsch Ges Inn Med; 1974; 80():1633-6. PubMed ID: 4454498
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pre-operative irradiation and tumor-specific immune response in hypernephroid renal carcinoma (author's transl)].
    Dietz R; Schwarze G; Pappas A
    Strahlentherapie; 1979 Jul; 155(7):466-9. PubMed ID: 115119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Suppression of leukocyte migration by autologous and allogeneic tumor extracts in kidney cancer patients].
    Novikov DK; Borisenko ID; Shein IA
    Vopr Onkol; 1978; 24(12):50-5. PubMed ID: 83731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tumor-specific immune response of hypernephroid renal carcinoma after in vitro irradiation (author's transl)].
    Dietz R; Schwarze G; Pappas A
    Strahlentherapie; 1979 Nov; 155(11):754-6. PubMed ID: 516095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous immune complex nephropathy associated with malignancy I. Studies on the nature and immunopathogenic significance of glomerular bound antigen and antibody, isolation and characterization of tumor specific antigen and antibody and circulating immune complexes.
    Ozawa T; Pluss R; Lacher J; Boedecker E; Guggenheim S; Hammond W; McIntosh R
    Q J Med; 1975 Oct; 44(176):523-41. PubMed ID: 53850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Aspects of the study of immunity in patients with kidney tumors].
    Trapeznikova MF; Kadagidze ZG; Abramian NS; Dutov VV
    Urol Nefrol (Mosk); 1984; (4):18-21. PubMed ID: 6474622
    [No Abstract]   [Full Text] [Related]  

  • 16. Immune RNA therapy for renal cell carcinoma: survival and immunologic monitoring.
    Ramming KP; deKernion JB
    Ann Surg; 1977 Oct; 186(4):459-67. PubMed ID: 907390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-mediated immunity in patients with renal adenocarcinoma.
    Bichler KH; Ax W; Tautz C
    Eur Urol; 1975; 1(5):231-4. PubMed ID: 61119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor membrane lymphocyte stimulation assay in patients with renal cell carcinoma.
    Hemstreet GP; Dawson JR; Seigler HF
    Cancer Res; 1978 May; 38(5):1447-56. PubMed ID: 646859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-mediated immunity to tumor antigens in patients with renal cell carcinoma.
    Cummings KB; Peter JB; Kaufman JJ
    J Urol; 1973 Jul; 110(1):31-5. PubMed ID: 4713354
    [No Abstract]   [Full Text] [Related]  

  • 20. Autologous mixed lymphocyte tumor cell culture in patients with renal cell carcinoma.
    Nakano E; Fujioka H; Ishibashi M; Matsuda M; Osafune M; Takaha M; Sonoda T
    J Urol; 1984 Feb; 131(2):223-6. PubMed ID: 6230462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.